Showing results (141-150 of 178) with videos related to
Sort By:
Pageof 18
Biochimica Et Biophysica Acta|June 7, 1976
Solid phase bovine thrombin. Preparation and propertiesS S Harwig, J L Lee, L A Sherman, et al.Radiology|July 1, 1980
Scintigraphy with 111In-labeled autologous platelets in venous thromboembolismH H Davis, B A Siegel, L A Sherman, et al.Endocrinology|January 1, 1996
Differential effects of insulin and exercise on Rab4 distribution in rat skeletal muscleL A Sherman, M F Hirshman, M Cormont, et al.European Journal of Immunology|April 1, 1992
Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cellsD Lo, J Freedman, S Hesse, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitusH T Kreuwel, D J Morgan, T Krahl, et al.Circulation Research|July 1, 1975
Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dogR E Coleman, S S Harwig, J F Harwig, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1977
Radioiodinated plasminogen: an imaging agent for pre-existing thrombiS L Harwig, J F Harwig, L A Sherman, et al.The Journal of Clinical Investigation|May 1, 1995
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjectsL J Goodyear, F Giorgino, L A Sherman, et al.Scandinavian Journal of Immunology|April 4, 2001
Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicityT R Petersen, S Buus, S Brunak, et al.Circulation|May 1, 1985
Fibrinopeptide A: a marker of acute coronary thrombosisP R Eisenberg, L A Sherman, K Schectman, et al.Pageof 18